Founded 17 years ago, Cevidra is an independent pharmaceutical company with a strong expertise in hospital affairs, particularly in tenders, and a vast network of experts. As a rapidly growing entity in the early access domain, Cevidra acts as a gateway to the French market for foreign companies. Rooted in innovation, agility, and commitment, Cevidra offers comprehensive services from its headquarters in Grasse, with additional offices in Paris and Lyon.

Holding GDP/GMP certifications, it excels as an « Exploitant » for pharmaceutical products, specializing in distribution through its logistical platform. Cevidra provides services ranging from regulatory affairs to market access and real-world data collection. It has a strong track record in managed access programs across various areas, including ATMPs.

As an Exploitant with an in-house GDP platform, Cevidra offers flexible support to foreign companies launching medicines in France. They handle compassionate/early access programs, market approval, and distribution, including market access and promotional activities in hospitals and pharmacies. Their tailored approach ensures a seamless entry into the French market.

–  Therapeutic areas: All therapeutic areas including Oncology, Rare diseases and Addictive medicine.

–  Based in: Grasse, Lyon and Paris (FRANCE)

–  Employees: 11 – 50

–  Created in: 2007